Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 177 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Abbvie US LLC paid sponsored hires in similar roles1 certified filing for “Medical Director, Clinical Development - Oncology” (Medical and Health Services Managers) in IL: $265k–$265k, median $265k.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 177 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Abbvie US LLC paid sponsored hires in similar roles
- 1 certified filing for “Medical Director, Clinical Development - Oncology” (Medical and Health Services Managers) in IL: $265k–$265k, median $265k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
The Biologics Analytical R&D (ARD) group supports innovative and unique early-stage biologics pipeline which includes mAbs, Bi- and multi-specifics, antibody drug conjugates (ADCs), Antibody Oligonucleotide Conjugates (AOCs), tLNPs, peptides and other biologic medicines. The team develops analytical methodologies and provides support to drug substance and drug product process and formulation development for traditional, high concentration, and complex formulations. Biologics ARD partners with all functions across Biologics CMC to deliver high-quality drug products for patients.
The Director, Biologics ARD will lead an Analytical Development Early Phase group within AbbVie’s Lake County (North Chicago headquarters) site. He/she will have accountability for multiple pipeline projects, development of relevant science and technology, people management, and implementation of functional strategies. He/she will ensure that the team’s deliverables are completed within established timelines, budgets, resource allocation and in accordance with regulatory, quality, and safety requirements.
The Ideal Candidate Will:
• Use a breadth of experience to drive phase-appropriate analytical development strategies to support AbbVie’s early phase pipeline through leadership and scientific expertise for the Early Phase group in Analytical Development.
• Responsibility and oversight of team-led analytical method development, validation, and transfer in line with global strategies.
• Drive alignment for early-phase biologics development across Biologics Analytical R&D and partner with department subfunctions to meet the Early Biologics Excellence milestones.
• Advance early-phase analytical development concepts fit for purpose to the growing and diversifying discovery biologics portfolio.
• Effectively manage organizational interfaces (Discovery, Synthetic Molecule CMC, Biologics CMC, CMC RA, PDS&T, Operations and QA).
Responsibilities:
• Accountable for early analytical method development, validation and quality control activities, technology transfers to internal and external labs and ensuring appropriate control strategies from candidate screening through Phase 1 and Phase 2 clinical studies.
• Ensures generation of ARD IND chapters for associated programs.
• Ensures alignment of analytical development concepts with Early Biologics Excellence playbook and contributes to the continued improvement of analytical acceleration levers.
• Partners with Development Science functions to select appropriate biologic candidates for development and to continuously improve the Biologics Screening Funnel requirements.
• Provide leadership and talent development for a team of 20+ analytical scientists, analytical leads and people leaders in Early Phase Analytical Development.
• Adapt to changing environments and balances priorities within Biologics Analytical R&D and ensures utilization of appropriately science-based approaches to ensure project and internal/external budget success and increase efficiency.
• Drive technological innovation and guide improvements to leverage scientific and operational excellence within Biologics Analytical R&D and in line with the Biologics CMC Development/AbbVie strategy for NBEs.
• Recruit, promote, and retain top talents via coaching and mentoring and assures effective succession planning.
• Promotes entrepreneurial thinking and makes smart business decisions while balancing risk.
• Proactively leads interfaces with other functions inside and outside of Biologics CMC Development and R&D.
• Assures compliance with AbbVie safety, quality and regulatory policies and government regulations.
• Ensures adequate support of multiple assigned CMC projects and contributes to project prioritization on a portfolio level.
• P
Apply on employer site ↗